Fact or Fiction: Debunking the Latest Anti-Vax Myths

| March 7, 2019

article image
With more than 100 confirmed cases of measles in the United States already this year, vaccines are once again squarely at the center of passionate national debate. At the heart of the issue are the concerns of parents about the safety of vaccines for their children. These concerns are pitted against the repeated assurances of health organizations including the Centers for Disease Control and Prevention (CDC) and American Academy of Pediatrics, doctors, and the larger scientific community, who have repeatedly stressed that childhood vaccines are safe and effective.

Spotlight

Orbona Pharma Ltd

Orbona Pharma Ltd is a privately held start up specialist pharmaceutical company dedicated to improving the lives’ of children with rare diseases. Established in late 2011 Orbona Pharma is developing two late stage drugs to treat a number of Orphan diseases. Between 50%-90% of medicines administered to children have not been developed for them (source: EMA and Eurodis) and often Medicines used are those for adults; administered to children by decreasing quantities based on weight, which can be extremely hazardous and is far from ideal. Orbona Pharma is working to address this. Orbona Pharma is working on two late stage drugs in oncology and immunology and is developing a pipeline of other candidates for development. Based in the UK, but with a network of experienced professionals in Europe, the US and elsewhere, Orbona is working hard to establish a global presence.

OTHER ARTICLES

Artificial intelligence in pharma: utilising a valuable resource

Article | March 11, 2020

The pharmaceutical industry is set to greatly benefit from the use of artificial intelligence (AI), due to its wide range of applications. Sydney Tierney discusses how machine learning can enhance marketing, manufacturing and drug trials. Artificial intelligence (AI) can be applied to nearly every aspect of the pharmaceutical and healthcare industry, to enhance data processing. Adopting the technology will reveal the astonishing potential of the healthcare sector, with success rates flying higher than ever before – especially in the research and development of crucial, life-changing drugs.

Read More

Pfizer Won’t Win the Coronavirus Pharma War

Article | March 11, 2020

Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?

Read More

How Can Medical Cannabis Help to Manage Pain Conditions? – The Cannabis Exchange

Article | March 11, 2020

Pain management is one of the most common reasons for the use of medical cannabis products. However, despite many jurisdictions – including Canada, Germany, and the Netherlands – now allowing the prescription of medical cannabis for this purpose, there remains little ‘high-quality’ evidence to support, or oppose its efficacy. Madden et al. (2018) set out to review the evidence available in order to determine the efficacy of medical cannabis when employed in the management of various forms of musculoskeletal pain. The researchers analysed various studies that assessed the use of cannabinoids in the treatment of arthritis pain; back pain; postoperative pain; and trauma-related pain. It is estimated that up to 30% of the population may suffer from a non-cancer-related pain condition. As such a high percentage of people suffer from these conditions, the development of simple and safe therapies is an essential area of research. This is particularly important as the therapeutic options for people with chronic pain are increasingly limited.

Read More

Top Pharmaceutical Firms Urge FDA to Adopt Blockchain for Drug Tracking

Article | March 11, 2020

Leading market participants in the United States pharmaceutical industry, logistics firms, distributors and other stakeholders in the pharma supply chain have come together to publish a report buttressing the need for industry players to adopt blockchain for tracking prescription drugs, following the successful completion of a DLT pilot project with the Food and Drug Administration (FDA), according to reports on February 24, 2020. Though nascent, blockchain technology, the building blocks of Bitcoin (BTC) and other cryptocurrencies are fast gaining ground across various ecosystems, due to its immutability, security, privacy, and other intricate properties. In the latest development, 25 leading manufacturers of pharmaceutical products, logistics partners and other market participants in the pharma supply chain, have published a report that highlights the importance of blockchain technology in drug traceability.

Read More

Spotlight

Orbona Pharma Ltd

Orbona Pharma Ltd is a privately held start up specialist pharmaceutical company dedicated to improving the lives’ of children with rare diseases. Established in late 2011 Orbona Pharma is developing two late stage drugs to treat a number of Orphan diseases. Between 50%-90% of medicines administered to children have not been developed for them (source: EMA and Eurodis) and often Medicines used are those for adults; administered to children by decreasing quantities based on weight, which can be extremely hazardous and is far from ideal. Orbona Pharma is working to address this. Orbona Pharma is working on two late stage drugs in oncology and immunology and is developing a pipeline of other candidates for development. Based in the UK, but with a network of experienced professionals in Europe, the US and elsewhere, Orbona is working hard to establish a global presence.

Events